-5%
Glipatab 10mg Tablet is used to lower blood sugar levels in adults with type 2 diabetes who have failed to achieve control by diet and exercise alone.
EMPAGLIFLOZIN is classified as an antidiabetic medication belonging to the group of sodium-glucose co-transporter-2 (SGLT2) inhibitors. It is prescribed for individuals with type 2 diabetes whose blood sugar levels cannot be adequately controlled through diet and exercise alone. Type 2 diabetes arises when the body either doesn’t produce enough insulin or the insulin it produces doesn’t function effectively.
The core component of Glipatab 10mg Tablet is empagliflozin. This active ingredient operates by inhibiting the sodium-glucose co-transporter-2 (SGLT-2) enzyme found in the kidney’s proximal tubules. This action curtails glucose reabsorption in the kidneys and enhances glucose excretion in urine by obstructing SGLT2. As a result, blood sugar levels are lowered in diabetic individuals.
Adhere to your prescribed regimen when taking Empagliflozin. Follow your doctor’s instructions and continue using the medication according to your medical needs. Potential side effects could include thrush, discomfort or burning sensation during urination, increased urination frequency, and mild skin rash or itching. Most of these side effects typically resolve on their own over time and do not demand immediate medical intervention. However, if these effects persist, consulting your doctor is recommended.
If you have allergies to any components of Empagliflozin, avoid its consumption. For pregnant or breastfeeding individuals, consulting a doctor before taking Empagliflozin is advised. It’s advisable to refrain from alcohol consumption while on Empagliflozin to prevent potential adverse reactions. Usage of Empagliflozin in children is limited and not recommended. Inform your doctor about your medication history and medical conditions to mitigate any potential undesirable interactions or side effects.